Signaling mechanisms, interaction partners, and target genes of STAT6

Hebenstreit, Daniel; Wirnsberger, Gerald; Horejs‐Hoeck, Jutta; Duschl, Albert

doi:10.1016/j.cytogfr.2006.01.004

Cited by 279 publications

(261 citation statements)

References 176 publications

Supporting

Mentioning

253

Contrasting

Unclassified

Order By: Relevance

“…These results would argue that IL-4 protection is routed through the maintenance of Akt activation by preserving pS 473 Akt and the suppression of BAD activity by maintaining pBAD phosphorylation rather than simply by regulating Bcl-xL protein expression. Since the regulation of Bcl-xL expression by IL-4 is known to be dependent on the STAT6 signaling pathway [13,14,56], it is reasonable to propose that IL-4 protects a variety of cell types from apoptosis by activating at least two independent signaling pathways leading to elevated Bcl-xL (STAT6 pathway) and suppression of BAD activity (IRS2/PI-3K/Akt pathway).…”

Section: Discussionmentioning

confidence: 99%

IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway

Carey

Семенова

et al. 2007

Cell Res

View full text Add to dashboard Cite

Interleukin-4 (IL-4) promotes lymphocyte survival and protects primary lymphomas from apoptosis. Previous studies reported differential requirements for the signal transducer and activator of transcription 6 (STAT6) and IRS2/phosphatidylinositol 3 kinase (PI-3K) signaling pathways in mediating the IL-4-induced protection from Fas-mediated apoptosis. In this study, we characterized IL-4-activated signals that suppress anti-IgM-mediated apoptosis and growth arrest of CH31, a model B-cell lymphoma line. In CH31, anti-IgM treatment leads to the loss of mitochondrial membrane potential, phospho-Akt, phospho-CDK2, and c-myc protein. These losses are followed by massive induction of p27 Kip1 protein expression, cell cycle arrest, and apoptosis. Strikingly, IL-4 treatment prevented or reversed these changes. Furthermore, IL-4 suppressed the activation of caspases 9 and 3, and, in contrast to previous reports, induced the phosphorylation (deactivation) of BAD. IL-4 treatment also induced expression of BclxL, a STAT6-dependent gene. Pharmacologic inhibitors and dominant inhibitory forms of PI-3K and Akt abrogated the anti-apoptotic function of IL-4. These results suggest that the IL-4 receptor activates several signaling pathways, with the Akt pathway playing a major role in suppression of the apoptotic program activated by anti-IgM.

show abstract

Section: Discussionmentioning

confidence: 99%

IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway

Carey

Семенова

et al. 2007

Cell Res

View full text Add to dashboard Cite

show abstract

“…If protein concentrations were not required, cells were lysed directly with 1ϫ SDS sample buffer. All samples were boiled for 5 min and subjected to Western analysis as described previously (19).…”

Section: In Vitro Stimulationsmentioning

confidence: 99%

SHIP Represses the Generation of IL-3-Induced M2 Macrophages by Inhibiting IL-4 Production from Basophils

Kuroda

Rüschmann

et al. 2009

The Journal of Immunology

102

100

View full text Add to dashboard Cite

There is a great deal of interest in determining what regulates the generation of classically activated (M1) vs alternatively activated (M2) macrophages (Mφs) because of the opposing effects that these two Mφ subsets have on tumor progression. We show herein that IL-3 and, to a lesser extent, GM-CSF skew murine Mφ progenitors toward an M2 phenotype, especially in the absence of SHIP. Specifically, the addition of these cytokines, with or without M-CSF, to adherence- or lineage-depleted (Lin−) SHIP−/− bone marrow (BM) cells induces high levels of the M2 markers, arginase I, and Ym1 in the resulting mature Mφs. These in vitro-derived mature Mφs also display other M2 characteristics, including an inability to enhance anti-CD3-stimulated splenic T cell secretion of IFN-γ and low IL-12 and high IL-10 production in response to LPS. Not surprisingly, given that IL-3 and GM-CSF utilize STAT5 to trigger many downstream signaling pathways, this M2 phenotype is suppressed when STAT5−/− BM cells are used. Unexpectedly, however, this M2 phenotype is also suppressed when STAT6−/− BM cells are used, suggesting that IL-4- or IL-13-induced signaling might be involved. Consistent with this, we found that IL-3 and GM-CSF stimulate the production of IL-4, especially from SHIP−/− Lin− BM cells, and that neutralizing anti-IL-4 Abs block IL-3-induced M2 skewing. Moreover, we found that basophil progenitors within the Lin− BM are responsible for this IL-3- and GM-CSF-induced IL-4 production, and that SHIP represses M2 skewing not by preventing skewing within Mφs themselves but by inhibiting IL-4 production from basophils.

show abstract

“…STAT6, a member of the STAT protein family, is central to IL-4 signal transduction (3)(4)(5)(6). STAT6 becomes phosphorylated by activated JAK1 and/or JAK3, dimerizes, and translocates into the nucleus where it binds to the germline IgE promoter (Iε).…”

mentioning

confidence: 99%

Control of the STAT6–BCL6 Antagonism by SWAP-70 Determines IgE Production

Audzevich

Pearce

Breucha

et al. 2013

The Journal of Immunology

View full text Add to dashboard Cite

Asthma and allergies are major health concerns in which Ig isotype E plays a pivotal role. Ag-bound IgE drives mast cells and basophils into exocytosis, thereby promoting allergic and potentially anaphylactic reactions. The importance of tightly regulated IgE production is underscored by severe immunological conditions in humans with elevated IgE levels. Cytokines direct IgH class-switching to a particular isotype by initiation of germline transcription (GLT) from isotype-specific intronic (I) promoters. The switch to IgE depends on IL-4, which stimulates GLT of the Iε promoter, but is specifically and strongly impaired in Swap-70−/− mice. Although early events in IL-4 signal transduction (i.e., activation of the JAK/STAT6 pathway) do not require SWAP-70, SWAP-70 deficiency results in impaired Iε GLT. The affinity of STAT6 to chromatin is reduced in absence of SWAP-70. Chromatin immunoprecipitation revealed that SWAP-70 binds to Iε and is required for association of STAT6 with Iε. BCL6, known to antagonize STAT6 particularly at Iε, is increased on Iε in absence of SWAP-70. Other promoters bound by BCL6 and STAT6 were found unaffected. We conclude that SWAP-70 controls IgE production through regulation of the antagonistic STAT6 and BCL6 occupancy of Iε. The identification of this mechanism opens new avenues to inhibit allergic reactions triggered by IgE.

show abstract

Signaling mechanisms, interaction partners, and target genes of STAT6

Cited by 279 publications

References 176 publications

IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway

IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway

SHIP Represses the Generation of IL-3-Induced M2 Macrophages by Inhibiting IL-4 Production from Basophils

Control of the STAT6–BCL6 Antagonism by SWAP-70 Determines IgE Production

Contact Info

Product

Resources

About